Quorum Health Corporation (QHC) Shares Bought by Ameriprise Financial Inc.

Ameriprise Financial Inc. increased its position in Quorum Health Corporation (NYSE:QHC) by 36.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 201,606 shares of the company’s stock after buying an additional 54,205 shares during the period. Ameriprise Financial Inc. owned 0.67% of Quorum Health Corporation worth $1,096,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its stake in Quorum Health Corporation by 17.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 967,565 shares of the company’s stock worth $7,034,000 after buying an additional 146,439 shares during the period. Acadian Asset Management LLC increased its stake in Quorum Health Corporation by 130.4% in the first quarter. Acadian Asset Management LLC now owns 549,342 shares of the company’s stock worth $2,989,000 after buying an additional 310,948 shares during the period. Guggenheim Capital LLC bought a new stake in Quorum Health Corporation during the fourth quarter worth about $1,651,000. Norges Bank bought a new stake in Quorum Health Corporation during the fourth quarter worth about $1,150,000. Finally, Wells Fargo & Company MN increased its stake in Quorum Health Corporation by 38.3% in the first quarter. Wells Fargo & Company MN now owns 82,478 shares of the company’s stock worth $449,000 after buying an additional 22,836 shares during the period. Institutional investors and hedge funds own 89.83% of the company’s stock.

Shares of Quorum Health Corporation (QHC) opened at 3.83 on Tuesday. The stock’s market cap is $116.06 million. The company’s 50-day moving average is $3.73 and its 200-day moving average is $6.26. Quorum Health Corporation has a 12-month low of $2.54 and a 12-month high of $11.59.

Quorum Health Corporation (NYSE:QHC) last posted its earnings results on Monday, May 15th. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.49) by $0.36. The company had revenue of $527.60 million for the quarter, compared to the consensus estimate of $548.81 million. Quorum Health Corporation had a negative net margin of 16.94% and a negative return on equity of 60.49%. The business’s quarterly revenue was down 4.0% on a year-over-year basis. On average, equities research analysts anticipate that Quorum Health Corporation will post ($1.58) earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This report was originally reported by Transcript Daily and is the property of of Transcript Daily. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://transcriptdaily.com/2017/07/18/quorum-health-corporation-qhc-shares-bought-by-ameriprise-financial-inc.html.

QHC has been the subject of a number of research analyst reports. Morgan Stanley initiated coverage on shares of Quorum Health Corporation in a report on Tuesday, June 6th. They set an “underweight” rating and a $3.00 price objective for the company. UBS AG restated a “sell” rating and set a $4.50 price objective (up previously from $4.00) on shares of Quorum Health Corporation in a report on Thursday, April 6th. Credit Suisse Group restated a “neutral” rating and set a $3.25 price objective (down previously from $5.00) on shares of Quorum Health Corporation in a report on Wednesday, May 17th. Finally, Deutsche Bank AG initiated coverage on shares of Quorum Health Corporation in a report on Tuesday, April 4th. They set a “hold” rating and a $5.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. Quorum Health Corporation presently has an average rating of “Hold” and an average target price of $4.58.

In related news, insider Thomas Daniel Miller bought 185,000 shares of the stock in a transaction on Thursday, May 18th. The shares were acquired at an average price of $2.85 per share, for a total transaction of $527,250.00. Following the purchase, the insider now owns 814,139 shares of the company’s stock, valued at $2,320,296.15. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Shaheed Koury bought 8,500 shares of the stock in a transaction on Thursday, May 25th. The shares were bought at an average price of $3.56 per share, for a total transaction of $30,260.00. Following the purchase, the senior vice president now directly owns 88,680 shares in the company, valued at approximately $315,700.80. The disclosure for this purchase can be found here. Insiders have acquired a total of 197,500 shares of company stock worth $568,190 in the last 90 days. Company insiders own 4.70% of the company’s stock.

Quorum Health Corporation Company Profile

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).

Institutional Ownership by Quarter for Quorum Health Corporation (NYSE:QHC)

Receive News & Ratings for Quorum Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply